Anti-Mullerian hormone levels in American girls by age and race/ethnicity
-
Swati V. Elchuri
,
Briana C. Patterson
Abstract
Background: Anti-Mullerian Hormone (AMH), a proposed indicator of ovarian follicle reserve in adults, has not been characterized in pediatric and adolescent females by race and/or ethnicity.
Objectives: To describe AMH levels in healthy American girls and determine the influence of age and race/ethnicity on AMH.
Subjects: Subjects aged 10–21 years were recruited from primary care settings and emergency departments. Race/ethnicity was characterized as White, Black or Hispanic.
Methods: Serum for AMH levels (ng/mL) was measured using an enzyme-linked immunosorbent assay.
Results: Thirty-one White, 60 Black and 24 Hispanic subjects were recruited. Mean AMH levels were 3.19 ng/mL (22.8 pmol/L) (SD 2.12) for Whites, 3.25 ng/mL (23.2 pmol/L) (SD 2.23) for Blacks and 2.97 ng/mL (21.2 pmol/L) (SD 1.75) for Hispanics. ANCOVA showed no difference in AMH levels among race/ethnicities, controlling for age (p=0.91). Age was significantly associated with AMH (p<0.001, R2=0.12).
Conclusion: AMH levels do not vary by race/ethnicity, and AMH levels increase with age.
Acknowledgments
Grant support from the Aflac Cancer And Blood Disorders Center and the Friends Research Fund, Children’s Healthcare of Atlanta. We would also like to acknowledge support from Morehouse School of Medicine, Children’s Healthcare of Atlanta, North Dekalb Health Center-Grady Health and University of Georgia Student Health Center for allowing us to recruit patients from clinics at those sites.
Conflict of interest statement: The authors have no conflicts of interest to disclose
References
1. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Mullerian Hormone: a new marker of ovarian function. Reproduction 2006;131:1–9.10.1530/rep.1.00529Suche in Google Scholar
2. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002;124:601–9.10.1530/rep.0.1240601Suche in Google Scholar
3. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065–71.10.1093/humrep/17.12.3065Suche in Google Scholar
4. Pangas SA. Regulation of the ovarian reserve by members of the transforming growth factor beta family. Mol Reprod Dev 2012;79:666–79.10.1002/mrd.22076Suche in Google Scholar
5. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH. A validated model of serum anti-Mullerian hormone from conception to menopause. PloS One 2011;6;e22024.10.1371/journal.pone.0022024Suche in Google Scholar
6. Kelsey TW, Anderson RA, Wright P, Nelson SM, Wallace WH. Data-drivenassessment of the human ovarian reserve. Mol Hum Reprod 2012;18:79–87.10.1093/molehr/gar059Suche in Google Scholar
7. Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Andersson AM, et al. Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod 2012;27: 861–6.10.1093/humrep/der435Suche in Google Scholar
8. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, et al. Antral follicle counts by transvaginal ultrasound are related to age in women with proven natural fertility. Fertil Steril 1999;72:845–51.10.1016/S0015-0282(99)00396-9Suche in Google Scholar
9. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91:705–14.10.1016/j.fertnstert.2007.12.013Suche in Google Scholar PubMed
10. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, et al. Fertility of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2009;27:2677–85.10.1200/JCO.2008.20.1541Suche in Google Scholar PubMed PubMed Central
11. Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, et al. Serum anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010;95:5003–10.10.1210/jc.2010-0930Suche in Google Scholar PubMed
12. Badik JR, Castañeda U, Gleason TJ, Spencer JB, Epstein MP, et al. Ovarian function in Duarte galactosemia. Fertil Steril 2011;96:469–73.10.1016/j.fertnstert.2011.05.088Suche in Google Scholar PubMed PubMed Central
13. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, te Velde ER, et al. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006;91:4057–63.10.1210/jc.2006-0331Suche in Google Scholar PubMed
14. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2007;134:196–201.10.1016/j.ejogrb.2007.01.012Suche in Google Scholar PubMed
15. Bentzen JG, Forman JL, Pinborg A, Lidegaard Ø, Larsen EC, et al. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod Biomed Online 2012;25:612–9.10.1016/j.rbmo.2012.09.001Suche in Google Scholar PubMed
16. Hadlow N, Longhurst K, McClements A, Natalwala J, Brown SJ, et al. Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response. Fertil Steril 2013:99:1791–7.10.1016/j.fertnstert.2013.01.132Suche in Google Scholar PubMed
17. Lie Fong S, Visser JA, Welt CK, de Rijke YB, Eijkemans MJ, et al. Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab 2012;97:4650–5.10.1210/jc.2012-1440Suche in Google Scholar PubMed PubMed Central
18. Fraser A, McNally W, Sattar N, Anderson EL, Lashen H, et al. Prenatal exposures and anti-Mullerian hormone in female adolescents: the Avon Longitudinal Study of Parents and Children. Am J Epidemiol 2013;178:1414–23.10.1093/aje/kwt137Suche in Google Scholar PubMed PubMed Central
19. Villarroel C, Merino PM, Lopez P, Eyzaguirre FC, Van Velzen A, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod 2011;26:2861–8.10.1093/humrep/der223Suche in Google Scholar PubMed
20. Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, et al. The prevalence of polycystic ovarian syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod 2014;29:791–801.10.1093/humrep/det469Suche in Google Scholar PubMed
21. Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos K, et al. Variations in serum mullerian inhibiting susbtance between white, black and Hispanic women. Fertil Steril 2009;92:1674–8.10.1016/j.fertnstert.2008.08.110Suche in Google Scholar PubMed PubMed Central
22. Bleil ME, Gregorich SE, Adler NE, Sternfeld B, Rosen MP, et al. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. Fertil Steril 2014;101: 199–207.10.1016/j.fertnstert.2013.09.015Suche in Google Scholar PubMed PubMed Central
23. Rustamov O, Smith A, Roberts SA, Yates AP, Fitzgerald C, et al. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod 2012;27:3085–91.10.1093/humrep/des260Suche in Google Scholar PubMed
24. MHRA (Medicines and Healthcare products Regulatory Agency). Urgent Field Safety Notice – FSN 20434-3 AMH Gen II ELISA (REF A79765), 2013. Available at: http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con297532.pdf. Accessed on June 7, 2014.Suche in Google Scholar
25. Steiner AZ, Stanczyk FZ, Patel S, Edelman A. Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception 2010;81:245–8.10.1016/j.contraception.2009.10.004Suche in Google Scholar PubMed PubMed Central
©2015 by De Gruyter
Artikel in diesem Heft
- Frontmatter
- Highlight: Childhood Craniopharyngioma
- Selected papers from the 3rd International Multidisciplinary Postgraduate Course, April 24–27, 2014
- Childhood craniopharyngioma – current status and recent perspectives in diagnostics and treatment
- The importance of interdisciplinary communication with patients about complex, chronic illnesses: our experiences as parents of a child with a craniopharyngioma
- Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
- Endocrine aspects and sequel in patients with craniopharyngioma
- Surgery for pediatric craniopharyngiomas: is less more?
- Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma
- Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience
- Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity
- Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment
- Review article
- Association study of TAC3 and TACR3 gene polymorphisms with idiopathic precocious puberty in Chinese girls
- Images in pediatric endocrinology
- Intestinal invagination in diabetic ketoacidosis: case report
- Original articles
- Managing incidental findings and disclosure of results in a paediatric research cohort – the LIFE Child Study cohort
- The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation
- Gender differences and age-related changes in body fat mass in Tibetan children and teenagers: an analysis by the bioelectrical impedance method
- A study of genes involved in adipocyte differentiation
- Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?
- The influence of puberty on vitamin D status in obese children and the possible relation between vitamin D deficiency and insulin resistance
- Growth failure associated with early neglect: pilot comparison of neglected US children and international adoptees
- Effect of growth hormone deficiency on brain MRI findings among children with growth restrictions
- Variability of lipid and lipoprotein concentrations during puberty in Brazilian boys
- Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth
- Can optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre study
- Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin
- Influence of catch-up growth on abdominal fat distribution in very low birth weight children – cohort study
- Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents
- Pulmonary function in children with type 1 diabetes mellitus
- Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation-dependent probe amplification
- Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial
- Vitamin D-containing supplements for children between 1–3 years of age: Are they essential for bone health?
- Anti-Mullerian hormone levels in American girls by age and race/ethnicity
- The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III
- Thyroid disease in Chinese girls with Turner syndrome
- Patient reports
- Pure gonadal dysgenesis (Swyer syndrome) due to microdeletion in the SRY gene: a case report
- Hypophosphatemic rickets caused by a novel splice donor site mutation and activation of two cryptic splice donor sites in the PHEX gene
- Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance
- A case of pediatric ectopic thyroid in lateral lymph nodes
- Hyperostosis-hyperphosphatemia syndrome (HHS): report of two cases with a recurrent mutation and review of the literature
- Needle detachment from the Sure-T® infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia
- Familial dysalbuminemic hyperthyroxinemia in a 4-year-old girl with hyperactivity, palpitations and advanced dental age: how gold standard assays may be misleading
Artikel in diesem Heft
- Frontmatter
- Highlight: Childhood Craniopharyngioma
- Selected papers from the 3rd International Multidisciplinary Postgraduate Course, April 24–27, 2014
- Childhood craniopharyngioma – current status and recent perspectives in diagnostics and treatment
- The importance of interdisciplinary communication with patients about complex, chronic illnesses: our experiences as parents of a child with a craniopharyngioma
- Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
- Endocrine aspects and sequel in patients with craniopharyngioma
- Surgery for pediatric craniopharyngiomas: is less more?
- Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma
- Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience
- Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity
- Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment
- Review article
- Association study of TAC3 and TACR3 gene polymorphisms with idiopathic precocious puberty in Chinese girls
- Images in pediatric endocrinology
- Intestinal invagination in diabetic ketoacidosis: case report
- Original articles
- Managing incidental findings and disclosure of results in a paediatric research cohort – the LIFE Child Study cohort
- The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation
- Gender differences and age-related changes in body fat mass in Tibetan children and teenagers: an analysis by the bioelectrical impedance method
- A study of genes involved in adipocyte differentiation
- Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?
- The influence of puberty on vitamin D status in obese children and the possible relation between vitamin D deficiency and insulin resistance
- Growth failure associated with early neglect: pilot comparison of neglected US children and international adoptees
- Effect of growth hormone deficiency on brain MRI findings among children with growth restrictions
- Variability of lipid and lipoprotein concentrations during puberty in Brazilian boys
- Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth
- Can optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre study
- Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin
- Influence of catch-up growth on abdominal fat distribution in very low birth weight children – cohort study
- Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents
- Pulmonary function in children with type 1 diabetes mellitus
- Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation-dependent probe amplification
- Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial
- Vitamin D-containing supplements for children between 1–3 years of age: Are they essential for bone health?
- Anti-Mullerian hormone levels in American girls by age and race/ethnicity
- The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III
- Thyroid disease in Chinese girls with Turner syndrome
- Patient reports
- Pure gonadal dysgenesis (Swyer syndrome) due to microdeletion in the SRY gene: a case report
- Hypophosphatemic rickets caused by a novel splice donor site mutation and activation of two cryptic splice donor sites in the PHEX gene
- Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance
- A case of pediatric ectopic thyroid in lateral lymph nodes
- Hyperostosis-hyperphosphatemia syndrome (HHS): report of two cases with a recurrent mutation and review of the literature
- Needle detachment from the Sure-T® infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia
- Familial dysalbuminemic hyperthyroxinemia in a 4-year-old girl with hyperactivity, palpitations and advanced dental age: how gold standard assays may be misleading
